Purpose: To report the prevalence and clinical significance of ocular findings in 20 patients with Menkes' syndrome recruited for a clinical trial at the National Institute of Child Health and Human Development (NICHHD).
Design: Retrospective observational case series.
Participants: Twenty patients with Menkes' syndrome enrolled in a clinical trial at the NICHHD, who underwent ophthalmic evaluation at the National Eye Institute from 1990 through 1997.
Methods: Review of clinical ophthalmic examination records, photographs, and visual evoked potential recordings.
Main Outcome Measures: Prevalence of ophthalmic signs of unusual frequency in patients with Menkes' syndrome.
Results: There was a high prevalence of very poor visual acuity (8 patients), myopia at 21 months old or younger (5 of 9 patients this age who underwent cycloplegic refraction), strabismus (11 of 18 patients whose motility was evaluated), blue irides (15 of 16 patients whose iris color was documented), iris stromal hypoplasia and bilateral peripheral transillumination (7 and 3 patients, respectively), peripheral retinal hypopigmentation (7 of 18 patients whose retinal periphery was noted at the initial examination), and aberrant eyelashes (5 patients).
Conclusions: Patients with Menkes' syndrome exhibit a high prevalence of several ocular findings, including some (very poor visual acuity, myopia, strabismus) that may warrant special care. Early ocular examination is thus indicated for patients with Menkes' syndrome, particularly those with mild variants of the disease, whose neurologic status is better and lifespan is longer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0161-6420(02)01095-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing.
Biomolecules
January 2025
Bioscience, Biotechnology and Biomedical Engineering Research Area, Japan Advanced Institute of Science and Technology, Nomi 923-1211, Japan.
RNA editing is a significant mechanism underlying genetic variation and protein molecule alteration; C-to-U RNA editing, specifically, is important in the regulation of mammalian genetic diversity. The ability to define and limit accesses of enzymatic machinery to avoid the modification of unintended targets is key to the success of RNA editing. Identification of the core component of the apoB RNA editing holoenzyme, APOBEC, and investigation into new candidate genes encoding other elements of the complex could reveal further details regarding APOBEC-mediated mRNA editing.
View Article and Find Full Text PDFCase Report: A male newborn with occipital horn syndrome.
F1000Res
November 2024
Neonatal Intensive Care Unit, King Fahad Medical City, Riyadh, Saudi Arabia.
Article Synopsis
- - Occipital horn syndrome (OHS) is a rare genetic disease linked to a defective ATP7A gene, affecting the copper transport system and primarily impacting musculoskeletal and connective tissues.
- - A male neonate diagnosed with OHS showed distinctive symptoms such as occipital exostosis, skin laxity at the nape, and widely opened skull sutures shortly after birth.
- - This case is significant as it stresses the need for thorough investigation of early symptoms and demonstrates the essential role of early diagnosis and collaborative care in improving outcomes for patients with OHS.
Nanoscale organization of cardiac calcium channels is dependent on thyroid hormone status.
Am J Physiol Heart Circ Physiol
November 2024
Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, United States.
Thyroid hormone dysfunction is frequently observed in patients with chronic illnesses including heart failure, which increases the risk of adverse events. This study examined the effects of thyroid hormones (THs) on cardiac transverse-tubule (TT) integrity, Ca sparks, and nanoscale organization of ion channels in excitation-contraction (EC) coupling, including L-type calcium channel (Ca1.2), ryanodine receptor type 2 (RyR2), and junctophilin-2 (Jph2).
View Article and Find Full Text PDFNovel, likely pathogenic variant in associated with Menkes disease diagnosed with ultrarapid genome sequencing.
BMJ Case Rep
October 2024
Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Article Synopsis
- - Menkes disease is a serious neurodegenerative disorder caused by problems with copper absorption, marked by symptoms like 'kinky' hair and developmental delays starting at 2-3 months old, and it follows an X-linked recessive inheritance pattern.
- - Historically, diagnosing Menkes has been challenging due to variable symptoms, often taking months, but new ultrarapid genome sequencing technology allows for quicker DNA-based diagnoses in just hours.
- - Recent case studies have used this sequencing tech to identify new genetic variants related to Menkes disease, paving the way for faster treatment and potentially better long-term health outcomes.
Phenotypic and mutational spectrum of 17 Chinese patients with Menkes Disease.
Neurol Sci
January 2025
Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Background: Menkes Disease (MD) is a fatal X-linked recessive disorder caused by mutations in the ATP7A gene. Severe cases typically die before the age of three. Mild MD and occipital horn syndrome are variants of MD characterized by a less severe phenotype and longer survival.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!